Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Entera Bio Ltd. (ENTX) vs REGENXBIO Inc. (RGNX)

Entera Bio Ltd. and REGENXBIO Inc. are both Biotechnology companies. Entera Bio Ltd. and REGENXBIO Inc. are of similar size ($487.8M and $486.7M). Entera Bio Ltd. grew revenue faster over the last twelve months: 66.4% against 12.0%. Entera Bio Ltd. has the higher net margin (0.00% vs −112.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Entera Bio Ltd. leads on 8 and REGENXBIO Inc. on 8.

Valuation

Metric ENTX RGNX Biotechnology median
P/E n/m n/m 7.88
P/S 622.15 2.24 11.47
P/B 19.09 5.45 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 540.72 2.12 10.73
Earnings yield (12.73%) (51.22%) (28.84%)
Free cash flow yield (7.92%) (63.88%) (23.03%)

Profitability

Metric ENTX RGNX Biotechnology median
Gross margin 0.00% 86.38% 65.16%
Operating margin 0.00% (94.08%) 0.00%
Net margin 0.00% (112.58%) 0.00%
Free cash flow margin 0.00% (143.09%) 0.00%
Return on equity (138.92%) (137.63%) (57.72%)
Return on assets (87.02%) (40.60%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTX RGNX Biotechnology median
Revenue growth (TTM) 66.42% 12.00% 5.64%
EPS growth (last fiscal year) 0.00% 18.08% —
Revenue growth, 5-year CAGR (29.19%) 1.97% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTX RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.98 2.86 4.73
Net debt to EBITDA 1.29 1.58 0.96

Dividend

Metric ENTX RGNX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENTX RGNX Biotechnology median
Market cap 486.74m 487.84m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack